132 related articles for article (PubMed ID: 17270001)
1. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
Yang HB; Cheng HC; Sheu BS; Hung KH; Liou MF; Wu JJ
Aliment Pharmacol Ther; 2007 Feb; 25(4):455-61. PubMed ID: 17270001
[TBL] [Abstract][Full Text] [Related]
2. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
[TBL] [Abstract][Full Text] [Related]
3. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
4. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
[TBL] [Abstract][Full Text] [Related]
5. Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Sheu BS; Tsai YC; Wu CT; Chang WL; Cheng HC; Yang HB
Helicobacter; 2013 Apr; 18(2):117-23. PubMed ID: 23067366
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetic balance in gastric mucosa with intestinal metaplasia after Helicobacter pylori eradication: 2-year follow-up study.
Wambura C; Aoyama N; Shirasaka D; Kuroda K; Watanabe Y; Miki I; Tamura T; Kasuga M
Dig Liver Dis; 2004 Mar; 36(3):178-86. PubMed ID: 15046186
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
10. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.
Suzuki M; Suzuki H; Masaoka T; Tanaka S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():158-64. PubMed ID: 15298622
[TBL] [Abstract][Full Text] [Related]
13. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma.
Lamarque D; Levy M; Chaumette MT; Roudot-Thoraval F; Cavicchi M; Auroux J; Courillon-Mallet A; Haioun C; Delchier JC
Am J Gastroenterol; 2006 Aug; 101(8):1886-93. PubMed ID: 16780555
[TBL] [Abstract][Full Text] [Related]
14. Alteration of E-cadherin expression in gastric mucosa: role of intestinal metaplasia and Helicobacter pylori infection.
Zullo A; Romiti A; Borrini F; Hassan C; Stella F; Sarcina I; Martini ME; Tomao S; Morini S; Mingazzini P
Anticancer Res; 2004; 24(3a):1603-7. PubMed ID: 15274329
[TBL] [Abstract][Full Text] [Related]
15. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
16. Intestinal metaplasia: evolution after Helicobacter pylori eradication and influence in the success of eradicating therapy.
Vázquez Romero M; Boixeda de Miquel D; Valer López-Fando MP; Albéniz Arbizu E; González Alonso R; Bermejo San José F
Rev Esp Enferm Dig; 2003 Nov; 95(11):781-4, 777-80. PubMed ID: 14640875
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication on bulbitis and duodenal gastric metaplasia.
Suriani R; Venturini I; Actis GC; Rocca G; Rizzetto M; Cerutti E; Mazzucco D; Cardesi E; Zeneroli ML
Hepatogastroenterology; 2004; 51(55):176-80. PubMed ID: 15011858
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?
de Vries AC; Kuipers EJ; Rauws EA
Am J Gastroenterol; 2009 Jun; 104(6):1342-5. PubMed ID: 19491846
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population].
Kim HJ; Choi BY; Byun TJ; Eun CS; Song KS; Kim YS; Han DS
J Prev Med Public Health; 2008 Nov; 41(6):373-9. PubMed ID: 19037166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
